Aevex Corp. (AVEX)
NYSEIndustrialsAerospace & DefenseSnapshot 2026-09-04
NYSEIndustrialsAerospace & DefenseSnapshot 2026-09-04
Research Workspace
Put AVEX beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Aerospace & Defense is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
No standing thesis yet — not enough to read.
View ThesisThis stock is volatile — it swings about 5% on a typical day and fell roughly 67% in its worst 12-month stretch.
View RiskAVEX's growth depends on its recent contract wins and acquisitions. The company won a $41 million contract and signed an agreement to acquire BlackSea Technologies. Revenue growth looks promising after these developments. AVEX trades at a low multiple compared to peers. Peer multiples imply a price about 41% above where it trades. The market cycle is currently in a "Mania" phase, which adds risk. The next-quarter miss probability is 23%. This read is provisional.
Trailing returns as of 2026-09-04. AVEX is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 9 analysts currently covering AVEX (as of Sep 2026).
Based on 7 Wall Street analysts offering 12-month price targets for AVEX in the last 4 months.
Continue this research
Compare AVEX with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| AVEX Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 2 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Aerospace & Defense — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put AVEX next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Securities fraud lawsuit could impact investor confidence.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $16.47
The last 12 months of price, then the range of analyst 12-month targets from today’s $16.47.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.

Securities fraud lawsuit could impact investor confidence.

Class action lawsuit indicates potential investor harm.

Class action lawsuit indicates potential investor harm.

Class action lawsuit indicates potential investor harm.

Class action lawsuit indicates potential investor harm.

Class action lawsuit indicates potential investor harm.

Class action lawsuit indicates potential investor harm.
